Patent ID: 7750028
Filing Date: 2010-07-06
Classification: A61P,C07D

Abstract:
1. A method of treating epilepsy comprising administering to a subject in need of such treatment a pharmaceutical composition, comprising a pharmaceutically acceptable carrier or diluent and a therapeutically effective amount of crystal modification A of the compound 1-(2,6-difluorobenzyl)-1 H-1,2,3-triazole-4-carboxamide of the formula characterized by characteristic lines at interplanar spacings (d values) of 10.5 Å, 5.14 Å, 4.84 Å, 4.55 Å, 4.34 Å, 4.07 Å, 3.51 Å, 3.48 Å, 3.25 Å, 3.19 Å, 3.15 Å, 3.07 Å and 2.81 Å, as determined by means of an X-ray powder pattern.